B-cell alterations in ME/CFS 'may suggest subtle tendency to autoimmunity' ProHealth However, treatment with anti-B-cell therapy using Rituximab has recently shown benefit to CFS patients. We therefore postulated that patients with CFS had a subtle humoral [found in the body fluids] immune dysfunction, and performed extended B-cell ... |
